ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, demonstrating that 88% of participants prefer EUR neffy® ...

The US Food and Drug Administration on Tuesday did not approve a needle-free epinephrine for treatment of severe allergic reactions, a move that drugmaker ARS Pharmaceuticals called surprising.

Patients at risk for anaphylaxis as well as caregivers of children at risk preferred needle-free epinephrine, according to ...

Add Yahoo as a preferred source to see more of our stories on Google. On August 9 the U.S. Food and Drug Administration (FDA) announced it had approved an epinephrine spray for emergency treatment of ...

ALK’s new data reveals 9 in 10 people prefer EURneffy, a needle-free nasal adrenaline spray, over auto-injectors: Denmark Monday, March 2, 2026, 18:00 Hrs [IST] ALK, a global sp ...

The Food and Drug Administration on Tuesday declined to approve a nasal spray that would have been the first needle-free alternative to injectors like EpiPen for treating severe allergic reactions, a ...

Q: I have been bothered by multiple allergies all my life, including pet dander; dust; mold; ragweed; grasses; oak pollen; cantaloupe and strawberries. I’ve thought about allergy shots to help ...

neffy 1 mg is the first approved needle-free epinephrine nasal spray for children aged 4 to 30 kg, addressing severe allergic reactions. ARS Pharmaceuticals announced the FDA approval of neffy 1 mg, ...

The FDA declined to approve an epinephrine nasal spray (ARS-1, also known as neffy), requesting that an additional premarketing study be conducted, maker ARS Pharmaceuticals announced. The company is ...

With summer here and school around the corner, allergy expert Dr. Nicole Chase shares tips on treating food allergies — including a needle-free option.